Drug Approval | April 20, 2026
Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Move strengthens footprint in Western India and expands multi-specialty care network
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
The investment case for health technology in India is frequently overstated in one direction and understated in another
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
Subscribe To Our Newsletter & Stay Updated
